Monkeypox Antibody Test Reagent Market - Global Forecast 2026-2032

The Monkeypox Antibody Test Reagent Market is moving toward a phase marked by quality-driven diagnostics and sustainable infrastructure, as global health stakeholders seek long-term solutions over short-term emergency management. Forward-looking decision-makers require a clear perspective on evolving compliance, innovation drivers, and supply strategies shaping this market.

Market Snapshot: Monkeypox Antibody Test Reagent Market Growth

The global Monkeypox Antibody Test Reagent Market is projected to increase from USD 153.53 million in 2025 to USD 174.34 million in 2026, achieving a forecasted CAGR of 11.79% and reaching USD 335.13 million by 2032. This momentum reflects expanded investment in laboratory readiness, as organizations strengthen procurement standards and optimize testing capabilities for emergent and sustained needs. Growing demand is evident among both public health programs and research organizations, with diverse use cases for serological testing and an emphasis on validated product performance.

Scope & Segmentation of the Monkeypox Antibody Test Reagent Market

This report presents a thorough analysis of the factors reshaping the Monkeypox antibody test reagent landscape, with a focus on buyer preferences, regional trends, and technology integration. It offers an in-depth breakdown of the key segments and operational considerations influencing both suppliers and end users.

Product Types: Complete assay kits and individual reagent components such as antigens, antibodies, buffers, calibrators, and controls form the basis of supplier offerings and end-user customization.
Assay Formats: Technologies include ELISA, rapid immunochromatographic assays, chemiluminescent immunoassays, and various automated immunoassay solutions, supporting both manual and automated laboratory environments.
Target Analytes: IgM, IgG, and total antibody approaches address a range of testing requirements, from acute infection detection and population surveillance to monitoring post-vaccination responses.
Sample Types: Serum and plasma are primary matrices, with growing use of alternative sample types guided by rigorous validation and performance controls.
End User Segments: Hospitals prioritize turnaround time and compatibility, while reference laboratories, public health programs, and research organizations focus on compliance, flexibility, and robust data output.
Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific show varying market maturity and infrastructure, requiring tailored supplier approaches based on governance and distribution capabilities.
Compliance & Documentation: Strong emphasis on validated claims, certificates of analysis, lot-to-lot comparability, and audit-ready documentation ensures reliability and facilitates regulatory alignment for institutional buyers.

Key Takeaways for Senior Decision-Makers

Procurement priorities have shifted from short-term emergency fulfillment towards acquiring validated, auditable solutions that meet long-term institutional requirements.
Market leadership demands a balance of scientific credibility, responsive supply chains, and strong post-sales technical support. Automation readiness and managed product changes add further value for complex buyers.
Differentiated demand reflects diverse priorities: hospitals require integrated solutions; public health agencies prioritize quality assurance and flexibility in stockpiling; research institutions need transparent, adaptable assay performance.
Integration of antibody test reagents into surveillance programs underscores the necessity of interoperability with laboratory information systems and a stable supply of controls and calibrators.
Industry convergence is accelerating as infectious disease assay expertise is redirected toward orthopoxvirus testing, highlighting the need for alignment with local regulatory and operational requirements across regions.

Tariff Impact and Procurement Strategy

Forthcoming United States tariffs in 2025 create additional complexity in global sourcing for the Monkeypox antibody test reagent market. Potential impacts extend to both finished reagents and essential upstream materials. Senior buyers can mitigate sourcing risks through dual-sourcing and robust change control, weighing factors such as total landed cost, freight, regulatory documentation, and optimized inventory management. Geographic diversification—through domestic production or regional warehousing—emerges as a practical advantage in a shifting policy landscape.

Methodology & Data Sources

This analysis draws on primary interviews with diagnostics manufacturers, laboratory leaders, and key stakeholders, complemented by secondary research on regulatory documentation, accreditation trends, corporate reporting, scientific literature, and logistics flows. Segmentation and regional insights are triangulated from multiple sources for practical, actionable clarity.

Why This Report Matters

Provides a segmented, up-to-date view of the Monkeypox antibody test reagent market to support confident procurement, supplier selection, and investment decisions.
Helps organizations manage sourcing risk, optimize supply chain design, and evaluate technology strategies in a context of evolving regulations and operational needs.
Offers practical guidance for integrating automation, meeting compliance demands, and building laboratory reliability in alignment with global public health goals.

Conclusion

The Monkeypox antibody test reagent market now stands out for increasing compliance rigor, regional variation, and technical integration. Providers that align product, operational, and documentation practices with dynamic user needs will be positioned to address the sector’s ongoing diagnostic challenges effectively.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Monkeypox Antibody Test Reagent Market, by Test Type

8.1. Iga
8.2. Igg
8.3. Igm

9. Monkeypox Antibody Test Reagent Market, by Technology Platform

9.1. Clia
9.2. Elisa
9.3. Rapid Lateral Flow
9.3.1. Colloidal Gold
9.3.2. Fluorescent

10. Monkeypox Antibody Test Reagent Market, by Sample Type

10.1. Plasma
10.2. Serum
10.3. Whole Blood

11. Monkeypox Antibody Test Reagent Market, by End User

11.1. Diagnostic Laboratory
11.2. Hospital
11.3. Public Health Laboratory
11.4. Research Institute

12. Monkeypox Antibody Test Reagent Market, by Application

12.1. Clinical Diagnosis
12.2. Epidemiological Surveillance
12.3. Research
12.4. Vaccine Development

13. Monkeypox Antibody Test Reagent Market, by Sales Channel

13.1. Offline
13.2. Online

14. Monkeypox Antibody Test Reagent Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Monkeypox Antibody Test Reagent Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Monkeypox Antibody Test Reagent Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Monkeypox Antibody Test Reagent Market
18. China Monkeypox Antibody Test Reagent Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AdvaCare Pharma Pvt. Ltd.
19.6. Applied DNA Clinical Labs, Inc.
19.7. Becton, Dickinson and Company
19.8. CerTest Biotec S.L.
19.9. FineTest International Co., Ltd.
19.10. Hangzhou AllTest Biotech Co., Ltd.
19.11. JOYSBIO Biotechnology Co., Ltd.
19.12. Laboratory Corporation of America Holdings
19.13. Mylab Discovery Solutions Pvt. Ltd.
19.14. Quest Diagnostics Incorporated
19.15. RayBiotech, Inc.
19.16. Roche Diagnostics GmbH
19.17. Sansure Biotech Inc.
19.18. Siemens Healthineers AG
19.19. Sino Biological Inc.
19.20. Vitrosens Diagnostics Pvt. Ltd.

List of Figures

FIGURE 1. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 108. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 109. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 123. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 124. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 125. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 140. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 141. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 142. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. ASEAN MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 148. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 149. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 150. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 151. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. GCC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 164. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 165. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 166. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 167. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. BRICS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 172. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 173. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 174. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 175. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. G7 MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 180. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 181. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 182. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 183. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. NATO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 197. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 198. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 199. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 200. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. CHINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Monkeypox Antibody Test Reagent market report include:

AdvaCare Pharma Pvt. Ltd.
Applied DNA Clinical Labs, Inc.
Becton, Dickinson and Company
CerTest Biotec S.L.
FineTest International Co., Ltd.
Hangzhou AllTest Biotech Co., Ltd.
JOYSBIO Biotechnology Co., Ltd.
Laboratory Corporation of America Holdings
Mylab Discovery Solutions Pvt. Ltd.
Quest Diagnostics Incorporated
RayBiotech, Inc.
Roche Diagnostics GmbH
Sansure Biotech Inc.
Siemens Healthineers AG
Sino Biological Inc.
Vitrosens Diagnostics Pvt. Ltd.

Table Information

Report Attribute	Details
No. of Pages	197
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 174.34 Million
Forecasted Market Value ( USD ) by 2032	$ 335.13 Million
Compound Annual Growth Rate	11.7%
Regions Covered	Global
No. of Companies Mentioned	17

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Market Snapshot: Monkeypox Antibody Test Reagent Market Growth

Scope & Segmentation of the Monkeypox Antibody Test Reagent Market

Key Takeaways for Senior Decision-Makers

Tariff Impact and Procurement Strategy

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Monkeypox Antigen Test Reagent Market - Global Forecast 2026-2032

Monkeypox Virus Antigen Detection Kit Market - Global Forecast 2025-2030

Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts 2022-2026

Monkeypox (MPOX) Diagnostics Global Markets 2024-2028, by Assay, by Country, by Product and by Place: Executive and Consultant Guides, Market Analysis and Forecasts

Monkey Pox Testing Market Report 2025